SUMO CRYGS 16-177 Q16C
(Plasmid
#217673)
-
PurposeN-terminally truncated human gamma S crystallin residues 16-177 with Q16C mutation for native chemical ligation
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 217673 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepET28B+
- Backbone size w/o insert (bp) 5368
- Total vector size (bp) 5854
-
Modifications to backbonenone
-
Vector typeBacterial Expression
Growth in Bacteria
-
Bacterial Resistance(s)Kanamycin, 50 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameCRYGS
-
SpeciesH. sapiens (human)
-
MutationGlutamine 16 changed to Cysteine, and amino acids 1-15 removed from gamma S crystallin
-
GenBank IDCRYGS
-
Entrez GeneCRYGS (a.k.a. CRYG8, CTRCT20)
- Promoter T7
-
Tags
/ Fusion Proteins
- 6XHis (N terminal on backbone)
- SUMO (N terminal on backbone)
Cloning Information
- Cloning method Unknown
- 5′ sequencing primer T7
- 3′ sequencing primer T7 term (Common Sequencing Primers)
Resource Information
-
A portion of this plasmid was derived from a plasmid made byDNASU HsCD00404131
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
This a N-terminally truncated gamma S crystallin missing its N-terminal 15 amino acid residues and containing a Q16C mutation at its N-terminus to act as a site to perform native chemical ligation. It also has a N-terminal SUMO tag with a 6X His tag with the amino acid sequence: GHHHHHHGSLQDSEVNQEAKPEVKPEVKPETHINLKVSDGSSEIFFKIKKTTPLRRLMEAFAKRQGKEMDSLRFLYDGIRIQADQAPEDLDMEDNDIIEAHREQ IGG
It will express in a soluble state with the SUMO tag, but will precipitate once the SUMO tag is removed during ulp-1 cleavage. It has a propensity to form non-disulfide linked multimers once the SUMO tag is removed, so the ligation reaction must be performed immediately after ULP-1 treatment.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
SUMO CRYGS 16-177 Q16C was a gift from Larry David (Addgene plasmid # 217673 ; http://n2t.net/addgene:217673 ; RRID:Addgene_217673)